Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine

NCT02406729 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

16935

Enrollment

OTHER_GOV

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: Dengue 1,2,3,4 (attenuated) vaccine
OTHER: Placebo

Sponsor

Butantan Institute